Role of NF2 haploinsufficiency in NF2-associated polyneuropathy

Brain Pathology

Volumn 17, Issue 4, 2007, Pages 371-376

  Hanemann, Clemens O ^a   Diebold, Ruth ^b   Kaufmann, Dieter ^b  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MERLIN; SHORT HAIRPIN RNA;

ALLELE; ARTICLE; CHROMOSOME 22; CONTROLLED STUDY; GENE DOSAGE; GENE LOCUS; GENE LOSS; GENE MUTATION; GENETIC ASSOCIATION; HAPLOIDY; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE BIOPSY; NEUROFIBROMATOSIS; POLYNEUROPATHY; PROTEIN EXPRESSION;

CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 22; DNA MUTATIONAL ANALYSIS; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HAPLOTYPES; HUMANS; NERVE FIBERS, MYELINATED; NEURAL CONDUCTION; NEUROFIBROMATOSIS 2; NEUROFIBROMIN 2; PERIPHERAL NERVES; POLYNEUROPATHIES; SCHWANN CELLS;

EID: 35148895013     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2007.00086.x     Document Type: Article

References (34)

1. Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans DG (2002) Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 59 : 1759 1765.
2. Baser ME, Kuramoto L, Woods R, Joe H, Friedman JM, Wallace AJ, Ramsden RT, Olschwang S, Bijlsma E, Kalamarides M, Papi L, Kato R, Carroll J, Lazaro C, Joncourt F, Parry DM, Rouleau GA, Evans DG (2005) The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2. J Med Genet 42 : 540 546.
3. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, Buchberg AM, Jenkins NA, Parada LF, Copeland NG (1994) Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 8 : 1019 1029.
4. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 : 156 159.
5. Cook DL, Gerber AN, Tapscott SJ (1998) Modeling stochastic gene expression: implications for haploinsufficiency. Proc Natl Acad Sci USA 95 : 15641 15646.
6. Deguen B, Goutebroze L, Giovannini M, Boisson C, van der NR, Jaurand MC, Thomas G (1998) Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of the NF2 gene. Int J Cancer 77 : 554 560.
7. Diebold R, Bartelt-Kirbach B, Evans DG, Kaufmann D, Hanemann CO (2005) Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction. J Mol Diagn 7 : 97 104.
8. Dow G, Biggs N, Evans G, Gillespie J, Ramsden R, King A (2005) Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural history? J Neurosurg Spine 2 : 574 579.
9. Evans DG (1999) Neurofibromatosis type 2: genetic and clinical features. Ear Nose Throat J 78 : 97 100.
10. Evans DG, Sainio M, Baser ME (2000) Neurofibromatosis type 2. J Med Genet 37 : 897 904.
11. Gijtenbeek JM, Gabreels-Festen AA, Lammens M, Zwarts MJ, van Engelen BG (2001) Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2. Neurology 56 : 1766 1768.
12. Gutmann DH, Loehr A, Zhang Y, Kim J, Henkemeyer M, Cashen A (1999) Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene 18 : 4450 4459.
13. Hagel C, Lindenau M, Lamszus K, Kluwe L, Stavrou D, Mautner VF (2002) Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens. Acta Neuropathol (Berl) 104 : 179 187.
14. Hanemann CO, Bartelt-Kirbach B, Diebold R, Kampchen K, Langmesser S, Utermark T (2006) Differential gene expression between human schwannoma and control Schwann cells. Neuropathol Appl Neurobiol 32 : 605 614.
15. Heinmoller E, Liu Q, Sun Y, Schlake G, Hill KA, Weiss LM, Sommer SS (2002) Toward efficient analysis of mutations in single cells from ethanol-fixed, paraffin-embedded, and immunohistochemically stained tissues. Lab Invest 82 : 443 453.
16. Ingram DA, Yang FC, Travers JB, Wenning MJ, Hiatt K, New S, Hood A, Shannon K, Williams DA, Clapp DW (2000) Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 191 : 181 188.
17. Iwata A, Kunimoto M, Inoue K (1998) Schwann cell proliferation as the cause of peripheral neuropathy in neurofibromatosis-2. J Neurol Sci 156 : 201 204.
18. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA (1994) Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7 : 353 361.
19. Kemkemer R, Schrank S, Vogel W, Gruler H, Kaufmann D (2002) Increased noise as an effect of haploinsufficiency of the tumor-suppressor gene neurofibromatosis type 1 in vitro. Proc Natl Acad Sci USA 99 : 13783 13788.
20. MacCollin M, Ramesh V, Jacoby LB, Louis DN, Rubio MP, Pulaski K, Trofatter JA, Short MP, Bove C, Eldridge R (1994) Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet 55 : 314 320.
21. Mautner VF, Tatagiba M, Lindenau M, Funsterer C, Pulst SM, Baser ME, Kluwe L, Zanella FE (1995) Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety. AJR Am J Roentgenol 165 : 951 955.
22. McClatchey AI, Saotome I, Mercer K, Crowley D, Gusella JF, Bronson RT, Jacks T (1998) Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 12 : 1121 1133.
23. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 : 1215.
24. Payne SR, Kemp CJ (2005) Tumor suppressor genetics. Carcinogenesis 26 : 2031 2045.
25. Ruttledge MH, andermann AA, Phelan CM, Claudio JO, Han FY, Chretien N, Rangaratnam S, MacCollin M, Short P, Parry D, Michels V, Riccardi VM, Weksberg R, Kitamura K, Bradburn JM, Hall BD, Propping P, Rouleau GA (1996) Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 59 : 331 342.
26. Santarosa M, Ashworth A (2004) Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochim Biophys Acta 1654 : 105 122.
27. Shuber AP, Ascano JJ, Boynton KA, Mitchell A, Frierson HF Jr., El Rifai W, Powell SM (2002) Accurate, noninvasive detection of Helicobacter pylori DNA from stool samples: potential usefulness for monitoring treatment. J Clin Microbiol 40 : 262 264.
28. Sperfeld AD, Hein C, Schroder JM, Ludolph AC, Hanemann CO (2002) Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2. Brain 125 : 996 1004.
29. Thomas PK, King RH, Chiang TR, Scaravilli F, Sharma AK, Downie AW (1990) Neurofibromatous neuropathy [see comments Muscle Nerve 13 : 93 101.
30. Utermark T, Alekov A, Lerche H, Abramowski V, Giovannini M, Hanemann CO (2003) Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells. Cancer 97 : 1955 1962.
31. Utermark T, Schubert SJ, Hanemann CO (2005) Rearrangements of the intermediate filament GFAP in primary human schwannoma cells. Neurobiol Dis 19 : 1 9.
32. Warren C, James LA, Ramsden RT, Wallace A, Baser ME, Varley JM, Evans DG (2003) Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation. J Med Genet 40 : 802 806.
33. Wu M, Wallace MR, Muir D (2006) Nf1 haploinsufficiency augments angiogenesis. Oncogene 25 : 2297 2303.
34. Zeng L, Fleury-Feith J, Monnet I, Boutin C, Bignon J, Jaurand MC (1994) Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies. Hum Pathol 25 : 227 234.